Astellas Pharma, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 10.40% vs 22.63% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 202.73% vs -772.91% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "571,206.00",
          "val2": "517,408.00",
          "chgp": "10.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "173,839.00",
          "val2": "130,682.00",
          "chgp": "33.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,446.00",
          "val2": "4,227.00",
          "chgp": "-42.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "100,323.00",
          "val2": "-97,660.00",
          "chgp": "202.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "218.30%",
          "val2": "153.70%",
          "chgp": "6.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 19.25% vs 5.60% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 197.72% vs -82.73% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,912,323.00",
          "val2": "1,603,672.00",
          "chgp": "19.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "454,804.00",
          "val2": "335,910.00",
          "chgp": "35.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14,349.00",
          "val2": "9,368.00",
          "chgp": "53.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-190,558.00",
          "val2": "-127,136.00",
          "chgp": "-49.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50,747.00",
          "val2": "17,045.00",
          "chgp": "197.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "133.70%",
          "val2": "111.00%",
          "chgp": "2.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

571,206.00

517,408.00

10.40%

Operating Profit (PBDIT) excl Other Income

173,839.00

130,682.00

33.02%

Interest

2,446.00

4,227.00

-42.13%

Exceptional Items

0.00

0.00

Consolidate Net Profit

100,323.00

-97,660.00

202.73%

Operating Profit Margin (Excl OI)

218.30%

153.70%

6.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 10.40% vs 22.63% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 202.73% vs -772.91% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1,912,323.00

1,603,672.00

19.25%

Operating Profit (PBDIT) excl Other Income

454,804.00

335,910.00

35.39%

Interest

14,349.00

9,368.00

53.17%

Exceptional Items

-190,558.00

-127,136.00

-49.89%

Consolidate Net Profit

50,747.00

17,045.00

197.72%

Operating Profit Margin (Excl OI)

133.70%

111.00%

2.27%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 19.25% vs 5.60% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 197.72% vs -82.73% in Mar 2024

All Annual Results